Omada Health president uses 1,843 shares for taxes

Omada Health’s president had 1,843 shares withheld or delivered for option exercise or tax obligations and now directly holds 299,349 shares.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that President Wei-Li Shao had 1,843 shares of common stock disposed of on September 5, 2026 to pay the exercise price or related tax liability by delivering or having shares withheld at $22.77 per share. After this administrative disposition, Shao directly holds 299,349 shares of Omada Health common stock, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Exercise Price or Tax Liability: 1,843 shares

Exercise Price or Tax Liability 1 txn

Insider Shao Wei-Li

Role President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,843	$22.77	$42K

Holdings After Transaction: Common Stock — 299,349 shares (Direct)

Key Figures

Shares disposed for exercise price or tax: 1,843 shares Per-share value for disposition: $22.77 per share Direct holdings after transaction: 299,349 shares

3 metrics

Shares disposed for exercise price or tax 1,843 shares Common stock used on September 5, 2026 to pay exercise price or tax liability

Per-share value for disposition $22.77 per share Value applied to the 1,843 Omada Health common shares delivered or withheld

Direct holdings after transaction 299,349 shares Omada Health common stock directly owned by President Wei-Li Shao after the September 5, 2026 disposition

FAQ

What insider transaction did Omada Health (OMDA) disclose for President Wei-Li Shao?

Omada Health disclosed that President Wei-Li Shao had 1,843 shares of common stock disposed of on September 5, 2026 to pay the exercise price or related tax liability by delivering or having shares withheld, at a reported value of $22.77 per share.

How many OMDA shares does President Wei-Li Shao hold after the reported Form 4 transaction?

After the reported disposition related to option exercise or tax obligations, President Wei-Li Shao directly holds 299,349 shares of Omada Health, Inc. common stock, as stated in the Form 4 filing.

Was the Omada Health (OMDA) insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 for Omada Health, Inc. indicates that the transaction for President Wei-Li Shao was not made pursuant to a Rule 10b5-1 trading plan; the trading-plan affirmation box is not checked.

What was the purpose of the 1,843-share disposition reported for OMDA’s president?

The 1,843-share disposition was reported as payment of the exercise price or tax liability by delivering or withholding Omada Health common shares, rather than as an open-market sale for investment purposes.

What price was used for the OMDA shares delivered or withheld in this insider transaction?

The shares delivered or withheld for Omada Health, Inc. were valued at $22.77 per share for the 1,843 shares used to satisfy the exercise price or related tax liability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 04:57 PM Accepted by SEC EDGAR 09/09/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2026		F		1,843	D	$22.77	299,349	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)